publications

April 12, 2018

Manuscript appears on bioRxiv

Congratulations to CSBL Ph.D. student Jess Wu, whose latest research has been published on the bioRxiv pre-print server! The paper, entitled “In silico mouse study identifies […]
February 9, 2018

New manuscript appears on bioRxiv

Congratulations to CSBL Ph.D. candidate Jennifer Rohrs, whose latest research has been published on the bioRxiv pre-print server! The paper, entitled “Computational model of chimeric antigen […]
November 18, 2017

New research published on bioRxiv

Over the Fall semester, the CSBLĀ  submitted three manuscripts to the bioRxiv pre-print server. Two of the manuscripts are now published! Qianhui Wu, and Stacey D. […]
May 19, 2017

Undergraduate CSBL researcher graduates

Congratulations to Thomas Gaddy, who graduated from The University of Southern California with a Bachelor’s of Science degree in Chemical Engineering! Thomas has made significant contributions […]
March 27, 2017

CSBL paper accepted for publication in Frontiers in Physiology

Congratulations to Dr. Mahua Roy, whose first paper from the lab was recently accepted for publication! Her paper, entitled “Computational model predicts the effects of targeting […]
October 21, 2016

CSBL paper published in new Nature Systems Biology journal

Congratulations to first author Jennifer Rohrs, co-author Christopher Sulistio, and Prof. Finley! Their computational model of the anti-angiogenic factor thrombospondin-1 (TSP1) has been published in the […]
April 16, 2016

CSBL paper is accepted in Cellular and Molecular Bioengineering

Jen Rohrs’ first-author paper has been accepted into the Cellular and Molecular Bioengineering journal! The paper, entitled “Predictive model of lymphocyte-specific protein tyrosine kinase (LCK) autoregulation”, […]
September 2, 2015

Professor Finley’s paper on anti-VEGF pharmacokinetics is accepted!

Congratulations to Professor Finley and co-authors Panos Angelikopoulos, Petros Koumoutsakos, andĀ Aleksander Popel, whose paper on computational modeling of anti-VEGF therapy in cancer patients was accepted for […]